Premorbid effects of APOE on synaptic proteins in human temporal neocortex

被引:83
作者
Love, Seth [1 ]
Siew, L. Khai
Dawbarn, David
Wilcock, Gordon K.
Ben-Shlomo, Yoav
Allen, Shelley J.
机构
[1] Univ Bristol, Dept Neuropathol, Inst Clin Neurosci, Frenchay Hosp, Bristol BS16 1LE, Avon, England
[2] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol BS1 3NY, Avon, England
[3] Univ Bristol, Dept Care & Elderly, Inst Clin Neurosci, Frenchay Hosp, Bristol BS16 1LE, Avon, England
[4] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England
基金
英国医学研究理事会;
关键词
Alzheimer's disease; apolipoprotein E; normal brain; postsynaptic density-95; synapse; synaptophysin; syntaxin; 1;
D O I
10.1016/j.neurobiolaging.2005.04.008
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
APOE affects the risk of Alzheimer's disease (AD) and course of several other neurologic diseases. Experimental studies suggest that APOE influences synaptogenesis. We measured the concentration of two presynaptic proteins, synaptophysin and syntaxin 1, and also postsynaptic density-95 (PSD95), in superior temporal cortex from 42 AD and 160 normal brains, and determined the APOE genotypes. The concentration of both presynaptic proteins was approximately two-thirds lower in AD than normal brains and that of PSD95 one-third lower. No effect of APOE on synaptic proteins was found in advanced AD. However, in normal brain, epsilon 4 was associated with lower concentrations of all three synaptic proteins and epsilon 2 with significantly elevated PSD95 (p = 0.03). A combined measure of synaptic proteins showed a significant linear decrease from epsilon 2 through epsilon 3 to epsilon 4 (p = 0.01). APOE influences the concentration of synaptic proteins in normal superior temporal cortex and may thereby affect the response to injury, and the risk and outcome of a range of neurologic diseases. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:797 / 803
页数:7
相关论文
共 63 条
[31]   ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory [J].
Levi, O ;
Jongen-Relo, AL ;
Feldon, J ;
Roses, AD ;
Michaelson, DM .
NEUROBIOLOGY OF DISEASE, 2003, 13 (03) :273-282
[32]   APOE and cerebral amyloid angiopathy in the elderly [J].
Love, S ;
Nicoll, JAR ;
Hughes, A ;
Wilcock, GK .
NEUROREPORT, 2003, 14 (11) :1535-1536
[33]  
LOVE S, 2000, NEUROPATHOL APPL NEU, V26, P203
[34]   Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease [J].
Lue, LF ;
Kuo, YM ;
Roher, AE ;
Brachova, L ;
Shen, Y ;
Sue, L ;
Beach, T ;
Kurth, JH ;
Rydel, RE ;
Rogers, J .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (03) :853-862
[35]   Apolipoprotein E - Structure, function, and possible roles in Alzheimer's disease [J].
Mahley, RW ;
Nathan, BP ;
Pitas, RE .
NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 :139-145
[36]   Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders [J].
Masliah, E ;
Heaton, RK ;
Marcotte, TD ;
Ellis, RJ ;
Wiley, CA ;
Mallory, M ;
Achim, CL ;
McCutchan, JA ;
Nelson, JA ;
Atkinson, JH ;
Grant, I ;
Chandler, JL ;
Wallace, MR ;
Spector, SA ;
Jernigan, T ;
Hesselink, J ;
Hansen, L ;
Abramson, I ;
Masys, D .
ANNALS OF NEUROLOGY, 1997, 42 (06) :963-972
[37]   IMMUNOELECTRON MICROSCOPIC STUDY OF SYNAPTIC PATHOLOGY IN ALZHEIMERS-DISEASE [J].
MASLIAH, E ;
HANSEN, L ;
ALBRIGHT, T ;
MALLORY, M ;
TERRY, RD .
ACTA NEUROPATHOLOGICA, 1991, 81 (04) :428-433
[38]  
MATSUMOTO S, 2003, NEUROLOGY, P60
[39]   Apolipoprotein E ε4 allele frequency is increased in Parkinson's disease only with co-existing Alzheimer pathology [J].
Mattila, PM ;
Koskela, T ;
Röyttä, M ;
Lehtimäki, T ;
Pirttila, TA ;
Ilveskoski, E ;
Karhunen, P ;
Rinne, JO .
ACTA NEUROPATHOLOGICA, 1998, 96 (04) :417-420
[40]   SYNERGISTIC EFFECTS OF TRAUMATIC HEAD-INJURY AND APOLIPOPROTEIN-EPSILON-4 IN PATIENTS WITH ALZHEIMERS-DISEASE [J].
MAYEUX, R ;
OTTMAN, R ;
MAESTRE, G ;
NGAI, C ;
TANG, MX ;
GINSBERG, H ;
CHUN, M ;
TYCKO, B ;
SHELANSKI, M .
NEUROLOGY, 1995, 45 (03) :555-557